Exceptionally huge bit of COVID-19 antibodies liable to be made in India: Gates Foundation CEO Kumar Jeetendra | October 21, 2020 A very large part of COVID-19 vaccines are likely to be manufactured in India through the country’s strong and robust private sector partners,” said Bill and Melinda Gates Foundation CEO Mark Suzman. In an interview with PTI, Suzman noted that India is doing what it can right now with the tools at hand to fight …
US preliminary of AstraZeneca COVID-19 immunization may continue this week: Sources Kumar Jeetendra | October 21, 2020 AstraZeneca Plc’s COVID-19 vaccine trial in the United States is expected to resume as early as this week following the U.S. Food and Drug Administration completed its review of a severe illness in a study participant, four sources told Reuters. AstraZeneca’s large, late-stage U.S. trial was on hold since Sept. 6, following a participant at …
SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines Kumar Jeetendra | October 21, 2020 Evaxion Biotech A/S has received funding from the Danish Innovation Fund to further develop their AI platform RAVEN to rapidly respond against future corona virus pandemics – from initial discovery to first in human trials in as little as 13 weeks. During those 13 weeks SB3000 intends to develop and validate a tailored μLOT® continuous …
Kewaunee Scientific Free Webinar on Biosafety & Biocontainment Kumar Jeetendra | October 22, 2020 Kewaunee Scientific is conducting a free webinar on Biosafety & Biocontainment on the 28th of October 2020. The webinar will focus on the basics of biosafety & biocontainment, followed with facility design and operational requirements. Viresh Sheth, Director & CEO of Shriyata Lifetech Pvt. Ltd., will conduct the webinar. Registration is free at https://zoom.us/webinar/register/WN_b4kGPX0oRlW__c8JMTCivg About …
SARS-CoV-2 Antibodies and Antigens for Diagnostic Kit Development Kumar Jeetendra | October 22, 2020 AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of SARS-CoV-2 antibodies and antigens to aid development of new immunoassay diagnostic kits. While RT-PCR diagnostic kits has provided fast and sensitive COVID-19 case confirmation, the technique suffers from some inherent drawbacks that limit …
XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation® Technology Kumar Jeetendra | October 22, 2020 SAN DIEGO, U.S.A., and FREISING, Germany, October 15, 2020 – Life Science Newswire – Antlia Bioscience, Inc., a privately owned biopharmaceutical company located in San Diego, California, and XL-protein GmbH, a privately owned biopharmaceutical company located in Germany, are pleased to announce a strategic slliance using XL-protein’s proprietary PASylation® technology for plasma half-life extension to …
Dublin-based start-up launch Wirano – a global digital platform for organizing clinical trials Kumar Jeetendra | October 22, 2020 Dublin, Ireland – 22 October 2020 – Life Science Newswire – A Dublin-based tech start-up today announced the launch of Wirano – a digital platform for the rapid and effective organization of clinical trials. The platform aims to revolutionize the activities involved in clinical trials by accelerating start-up of trials, optimizing patient recruitment, and improving …
Atik Cameras Develops New Products for Use with qPCR Instruments for Accurate, Reliable COVID-19 Testing Kumar Jeetendra | October 22, 2020 NORWICH, UK – (October 22, 2020) – Life Science Newswire – In response to global demand for dependable technologies designed to optimize COVID-19 testing, Atik Cameras, specialist designer and manufacturer of advanced scientific imaging solutions, has developed the new VS255 and VS825 cameras for use specifically with quantitative Polymerase Chain Reaction (qPCR) instruments — the …
Poor intimate hygiene linked to being one of the biggest causes of cervical cancer Kumar Jeetendra | October 22, 2020 Cervical cancer is becoming one of the emerging health burdens for womanhood. Cervical cancer is the fourth most common type of cancer for women worldwide, but also one of the most preventable types of cancer. Most cervical cancer cases are caused by the sexually transmitted human papilloma virus (HPV). According to the data released in 2018 by the HPV Centre, in India, cervical …
Aurobindo Pharma agreement: CCMB creating evidence of idea for COVID-19 antibody Kumar Jeetendra | October 22, 2020 Hyderabad, Oct 22 (PTI) The CSIR-Centre for Cellular and Molecular Biology has set in motion the procedure for development of a COVID-19 vaccine candidate as part of a pact with Aurobindo Pharma, a top official of the premier institute said on Thursday. It had been in the process of creating a proof of concept for …
Bharat Biotech’s Covaxin gets endorsement for Phase III preliminaries: Reports Kumar Jeetendra | October 23, 2020 Bharat Biotech’s coronavirus vaccine Covaxin has obtained approval for carrying out Phase III trials on October 22, reports suggest. The approvals were reportedly given after analyzing data from Phase I and II and animal challenge study. Phase III is very likely to start next month, Business Today reported. The report stated a professional committee met …
Bruker presents Vutara™ VXL tbest-in-class super-resolution magnifying lens and spatial science investigation abilities Kumar Jeetendra | October 23, 2020 Vutara VXL serves as a biological microscopy workstation for research on DNA, RNA and proteins, from macromolecular complexes and super-structures, to chromatin structure and chromosomal substructures, to studying functional connections in genomes and in various subcellular organelles. This novel system supports innovative spatial biology research in extracellular matrix structures, extracellular vesicles (EV), virology, neuroscience, and …
